trial

A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine

NCTId NCT01015001
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 20 (actual)
Sponsored by Hospital de Clinicas de Porto Alegre
Primary completion 2009-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2008-05
Primary completion
2009-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
(1Hz) rTMS applied over the left temporoparietal cortex

Sponsors

Hospital de Clinicas de Porto AlegreLead Sponsor

Investigators

2
Danilo Jesus, PsychiatristPrincipal Investigator
Paulo B Abreu, phdStudy Director

Sites

1 total
Porto Alegre, Brazil

Linked catalysts

1
A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic S — primary completion2009-12

Facts & assertions

4 sourced
Enrollment
20
Phase
PHASE3
Primary Completion Date
2009-12
Status
COMPLETED
relationships
The graph out of here
drug
(1Hz) rTMS applied over the left temporoparietal cortex
drug
lead_sponsor
Hospital de Clinicas de Porto Alegre
company
indication
Hallucinations
indication
Auditory Hallucinations
indication
Schizophrenia
indication
investigator
Danilo Jesus, Psychiatrist
person
Paulo B Abreu, phd
person